Showing all 3 results

  • Medical Device Distributors - Malaysia & Indonesia

    Database of Medical Device Distributors in Malaysia & Indonesia

    $ 390.00

    ASEAN region offers strong potential for medical device manufacturers. Indonesia is the fastest growing market in the region at present, while Malaysia offers several business advantages including ease of market entry and availability of modern health care infrastructure. Malaysia also offers the option of being the strategic entry point to ASEAN market.

    Success in both the countries requires partnership with local distributors with strong connections with hospitals, clinics, government sectors and other end-user segments. This database, which offers detailed profiles of 275 distributors in Indonesia and 80 distributors in Malaysia will serve as a good tool for foreign medical device companies for screening and be identifying potential distributors in Indonesia and Malaysia

  • Indonesia Medical Devices Distributors Database

    Database of Medical Device Distributors in Indonesia

    $ 350.00

    Indonesia is a fast growing healthcare market. This growth is expected to continue at least for the next two years, based on the government's focus to offer universal health care coverage for all of its citizens. This is offering extensive opportunities for medical device companies worldwide.Entering Indonesia market, however, poses significant challenges. For a foreign company, success depends on their local distributors.

    This database is part of our continuing effort to list all the medical device distributors in Indonesia. This is an updated version of the previous database published in November 2016 by AcuBiz. This updated version offers profiles of 275 medical device distributors in Indonesia.

  • Clinical Lateral Flow Assay Markets in Indonesia

    $ 1,200.00

    The success of home-based pregnancy tests in lateral flow format has been instrumental in the growth of lateral flow immunoassay (LFIA) as a platform accepted across widely different application segments. Ease of use combined with accuracy in the majority of situations is driving the clinical use of LFIA tests for the diagnosis of various infectious diseases, cancer, cardiac disease, and drug of abuse tests.

    While developed markets such as North America and Europe have the highest market demand for these products, the Asia-Pacific region is the fastest growing market for these tests. Indonesia’s healthcare market is on the verge of rapid growth at this point, as the government is taking steps to improve access to quality healthcare for its population by implementing universal health coverage (UHC) for 100% of its population by 2019.